From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease

Brain Research
Arianna BellucciPierfranco Spano

Abstract

Alpha-synuclein is a natively unfolded protein playing a key role in the regulation of several neuronal synaptic functions in physiological and pathological conditions. Many studies, over the past years, have shown that it is actively involved in PD pathophysiology. Alpha-synuclein is integrated in a complex network of neuronal processes through the interaction with cytosolic and synaptic proteins. Hence, it is not the sole α-synuclein pathology but its effects on diverse protein partners and specific cellular pathways in the membrane and/or cytosolic districts such as endoplasmic reticulum/Golgi, axonal and synaptic compartments of dopaminergic neurons, that may cause the onset of neuronal cell dysfunction and degeneration which are among the key pathological features of the PD brain. Here we summarize a series of experimental data supporting that α-synuclein aggregation may induce dysfunction and degeneration of synapses via these multiple mechanisms. Taken together, these data add new insights into the complex mechanisms underlying synaptic derangement in PD and other α-synucleinopathies. This article is part of a Special Issue entitled: Brain Integration.

References

Nov 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·G LennoxR B Godwin-Austen
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K UédaT Saitoh
May 23, 1998·The Journal of Biological Chemistry·W S DavidsonJ M George
Oct 3, 1998·The Journal of Biological Chemistry·P H JensenM Goedert
Oct 9, 1999·The American Journal of Pathology·D W DicksonS H Yen
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·L C SerpellR A Crowther
Aug 1, 2000·The Journal of Biological Chemistry·E JoP E Fraser
Apr 5, 2001·Journal of Molecular Biology·D EliezerG Browne
Apr 9, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·F J LeeH B Niznik
Aug 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·R SharonD J Selkoe
Sep 13, 2001·The Journal of Biological Chemistry·R J PerrinJ M George
Apr 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·M F PerutzE Scherzinger
May 16, 2002·Journal of the History of the Neurosciences·Bernd Holdorff
Jun 19, 2002·Acta Neuropathologica·John E DudaJohn Q Trojanowski
Oct 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·William DauerRene Hen
Nov 13, 2002·Biochemistry·Thomas D KimChul-Hak Yang
Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Feb 15, 2003·The Journal of Biological Chemistry·Sreeganga ChandraThomas C Südhof
Apr 26, 2003·Science·Benoit I GiassonVirginia M-Y Lee

❮ Previous
Next ❯

Citations

Sep 21, 2013·International Journal of Molecular Sciences·Liang HuangHoward J Federoff
Dec 7, 2013·International Journal of Cell Biology·Gunnar K Gouras
Feb 13, 2013·Journal of the American Chemical Society·Thomas GurryCollin M Stultz
Mar 6, 2013·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Marcel BenadibaGeraldo Busatto Filho
Mar 26, 2015·Frontiers in Neuroscience·Scarlet GallegosLuis G Aguayo
Feb 3, 2015·Nature Chemical Biology·Céline GalvagnionChristopher M Dobson
Jun 29, 2014·Biochimica Et Biophysica Acta·Dezerae CoxHeath Ecroyd
Jul 28, 2016·Neurotoxicology·Harm J HeusinkveldRoel P F Schins
Dec 1, 2017·Molecular Brain·Lesly PuspitaJae-Won Shim
Jul 30, 2014·Laboratory Investigation; a Journal of Technical Methods and Pathology·Nadia O PostupnaMartin Darvas
Jun 16, 2012·Expert Opinion on Therapeutic Patents·Wassilios G Meissner
Jan 8, 2013·Neuropathology and Applied Neurobiology·T H Gillingwater, T M Wishart
May 15, 2013·The FEBS Journal·Paul M A AntonyRudi Balling
Dec 26, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Ann-Louise BergströmKarina Fog
Jan 18, 2020·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·Amin A Seleem
Apr 30, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Heather WilsonMarios Politis
Nov 28, 2015·Neuropathology and Applied Neurobiology·Arianna BellucciPierFranco Spano
May 10, 2017·Neurotoxicity Research·Patricia S Muñoz, Juan Segura-Aguilar
Jun 10, 2020·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Majken Borup ThomsenAnne M Landau
Jun 24, 2017·The Journal of Biological Chemistry·Ana Jorge-FinniganAurora Martinez
Feb 11, 2020·Frontiers in Cellular Neuroscience·Eric N AndersonShermali Gunawardena
Mar 14, 2019·Frontiers in Cellular Neuroscience·Christopher M HenstridgeRosa C Paolicelli
May 21, 2019·Frontiers in Molecular Neuroscience·Eftychia VasiliTiago Fleming Outeiro
Aug 25, 2020·Oxidative Medicine and Cellular Longevity·Alejandra Guillermina Miranda-DíazErnesto Germán Cardona-Muñoz
Nov 13, 2012·Chembiochem : a European Journal of Chemical Biology·Nicholas P MarottaMatthew R Pratt
Nov 21, 2020·International Journal of Molecular Sciences·Dominika FricovaAlzbeta Kralova Trancikova
Mar 9, 2021·Frontiers in Immunology·Tizibt Ashine BogaleArianna Bellucci
May 15, 2015·Journal of Cell Science·Michela ZaltieriArianna Bellucci
Jul 13, 2021·Frontiers in Cellular Neuroscience·Monika Jankowska-KieltykaIrena Nalepa
Aug 3, 2021·Experimental Cell Research·Pritam Kumar RoyMahitosh Mandal
Oct 31, 2021·Journal of Food Biochemistry·Masood Sadiq ButtMuhammad Rizwan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.